JP2004508017A5 - - Google Patents

Download PDF

Info

Publication number
JP2004508017A5
JP2004508017A5 JP2002512413A JP2002512413A JP2004508017A5 JP 2004508017 A5 JP2004508017 A5 JP 2004508017A5 JP 2002512413 A JP2002512413 A JP 2002512413A JP 2002512413 A JP2002512413 A JP 2002512413A JP 2004508017 A5 JP2004508017 A5 JP 2004508017A5
Authority
JP
Japan
Prior art keywords
seq
exon
depending
nucleotide sequence
ugt1a7
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002512413A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004508017A (ja
JP3947103B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2001/007524 external-priority patent/WO2002006523A2/en
Publication of JP2004508017A publication Critical patent/JP2004508017A/ja
Publication of JP2004508017A5 publication Critical patent/JP2004508017A5/ja
Application granted granted Critical
Publication of JP3947103B2 publication Critical patent/JP3947103B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002512413A 2000-07-14 2001-07-02 肝細胞毒性に対する素因を検出する方法 Expired - Fee Related JP3947103B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00115353 2000-07-14
PCT/EP2001/007524 WO2002006523A2 (en) 2000-07-14 2001-07-02 Method for detecting pre-disposition to hepatotoxicity

Publications (3)

Publication Number Publication Date
JP2004508017A JP2004508017A (ja) 2004-03-18
JP2004508017A5 true JP2004508017A5 (https=) 2005-02-03
JP3947103B2 JP3947103B2 (ja) 2007-07-18

Family

ID=8169277

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002512413A Expired - Fee Related JP3947103B2 (ja) 2000-07-14 2001-07-02 肝細胞毒性に対する素因を検出する方法

Country Status (5)

Country Link
US (1) US20040076968A1 (https=)
EP (1) EP1325152A2 (https=)
JP (1) JP3947103B2 (https=)
AU (1) AU2001281930A1 (https=)
WO (1) WO2002006523A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395481B1 (en) * 1999-02-16 2002-05-28 Arch Development Corp. Methods for detection of promoter polymorphism in a UGT gene promoter
US20030099960A1 (en) * 2001-01-26 2003-05-29 The University Of Chicago Compositions and methods for optimizing UGT2B7 substrate dosings and for predicting UGT2B7 substrate toxicity
DE10207971A1 (de) * 2002-02-25 2003-09-11 Norbert Dahmen Verfahren zur Identifizierung Nebenwirkungs-relevanter Markerprofile
AU2003228425A1 (en) * 2002-04-01 2003-10-20 Phase-1 Molecular Toxicology, Inc. Liver necrosis predictive genes
US20040203034A1 (en) * 2003-01-03 2004-10-14 The University Of Chicago Optimization of cancer treatment with irinotecan
ES2308208T3 (es) 2003-05-30 2008-12-01 University Of Chicago Metodos y composiciones para predecir la toxicidad del irinotecano.
US20090247475A1 (en) * 2004-03-05 2009-10-01 The Regents Of The University Of California Methods and compositions relating to pharmacogenetics of different gene variants in the context of irinotecan-based therapies
WO2006027182A1 (en) * 2004-09-06 2006-03-16 Medizinische Hochschule Hannover Methods and its kits based on ugt1a7 promoter polymorphism
WO2006070666A1 (ja) * 2004-12-28 2006-07-06 Takara Bio Inc. 遺伝子多型の同時検出方法
EP1790343A1 (en) * 2005-11-11 2007-05-30 Emotional Brain B.V. Pharmaceuticals formulations and uses thereof in the treatment of female sexual dysfunction
CN106755388B (zh) * 2016-11-24 2019-08-23 厦门艾德生物医药科技股份有限公司 一种改进的ARMS引物结构(Super-ARMS)及其使用方法
CN108315420A (zh) * 2018-04-04 2018-07-24 广西中医药大学附属瑞康医院 一种用于检测乙肝癌变多态性的试剂盒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992012987A1 (en) 1991-01-10 1992-08-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services The genetic locus ugt1 and a mutation therein
TW221441B (https=) 1991-01-25 1994-03-01 Taiho Pharmaceutical Co Ltd
JP2000508912A (ja) 1996-04-19 2000-07-18 スペクトラ バイオメディカル,インコーポレイテッド 多型形態と複数の表現型との相関付け
GB2321190B (en) * 1997-01-16 2000-09-20 Britannia Pharmaceuticals Ltd Pharmaceutical composition
EP1084271A2 (en) * 1998-05-07 2001-03-21 Axys Pharmaceuticals, Inc. Genotyping the human udp-glucuronosyltransferase 1 (ugt1) gene

Similar Documents

Publication Publication Date Title
Telatar et al. Ataxia-telangiectasia: mutations in ATM cDNA detected by protein-truncation screening
McGuire et al. Identification of the structural mutation responsible for the dibucaine-resistant (atypical) variant form of human serum cholinesterase.
Anglicheau et al. Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients
JP4276691B2 (ja) 男性不妊関連遺伝子プロタミン−2変異と男性不妊の診断方法
JP2004508017A5 (https=)
CA2782207A1 (en) Polymorphisms associated with parkinson's disease
WO2009036100A2 (en) Prediction of qt prolongation based on snp genotype
WO1999029903A2 (en) Cancer susceptibility mutations of brca1
ES2252159T3 (es) Polimorfismos en el gen humano del transportador de anion organico c (oatp-c).
CN100379881C (zh) 皮肤处理
Price et al. Analysis of the HNF4 α gene in Caucasian Type II diabetic nephropathic patients
WO2014043558A1 (en) Methods of predicting the development of amd based on chromosome 1 and chromosome 10
JP2003500067A5 (https=)
US20130023442A1 (en) Single nucleotide polymorphism for predicting recurrence of hepatocellular carcinoma
WO2002006523A3 (en) Method for detecting pre-disposition to hepatotoxicity
Ye et al. Identification of novel mutations of IRF6 gene in Chinese families with Van der Woude syndrome
Thonglairoam et al. Hemoglobin constant spring in bangkok: Molecular screening by selective enzymatic amplification of the α2‐globin gene
US20060257850A1 (en) Methods of treatment and diagnosis of patients with hepatitis c infection
RU2005127807A (ru) Применение нового полиморфизма в гене hsgki для диагностики гипертонии и применение генов семейства sgk для диагностики и терапии синдрома удлиненного q/t-периода
JP2007516719A (ja) 一塩基多型を含む二型糖尿病に関与するポリヌクレオチド、それを含むマイクロアレイ及び診断キット、並びにそれを利用したポリヌクレオチドの分析方法
Matsumoto et al. Genetic diagnosis of Werner's syndrome, a premature aging disease, by mutant allele specific amplification (MASA) and oligomer ligation assay (OLA)
KR101360408B1 (ko) 좌심실비대와 연관된 단일염기다형성 및 그의 용도
JP2007014244A (ja) 心室伝導障害または心室細動の遺伝的素因を検査する方法、およびそのための試薬
AU2001260263B2 (en) Method and probes for the genetic diagnosis of hemochromatosis
JP4348456B2 (ja) グルココルチコイド製剤への感受性の遺伝子診断に用いることができる変異型ポリヌクレオチドおよび核酸分子